{
  "timestamp": "2026-03-01T16:51:59.863393+00:00",
  "feed_lines": 506,
  "recent_feed": [
    "{\"topic\": \"options-flow-slv\", \"domain\": \"camel-finance\", \"finding\": \"SLV options: fetch failed\", \"source\": \"yahoo-options-slv\", \"instrument\": \"SLV\", \"url\": \"https://query1.finance.yahoo.com/v7/finance/options/SLV\", \"timestamp\": \"2026-03-01T16:40:39Z\"}",
    "{\"topic\": \"treasury-auction-calendar\", \"domain\": \"treasury-bonds\", \"finding\": \"Upcoming auctions: 13-Week on 2026-03-02T00:00:00 ($89000000000B) | 26-Week on 2026-03-02T00:00:00 ($77000000000B) | 6-Week on 2026-03-03T00:00:00 ($90000000000B) | 17-Week on 2026-03-04T00:00:00 ($B)\", \"source\": \"treasurydirect\", \"instrument\": \"TLT\", \"url\": \"https://www.treasurydirect.gov/TA_WS/securities/upcoming\", \"timestamp\": \"2026-03-01T16:40:39Z\"}",
    "{\"timestamp\":\"2026-02-27T10:00:00Z\",\"topic\":\"treasury-bonds\",\"finding\":\"The US 10-year Treasury yield trades near 4.5 percent in early 2026 as the Fed holds rates steady.\",\"source\":\"fallback\"}",
    "{\"timestamp\": \"2026-03-01T16:43:00Z\", \"topic\": \"longevity\", \"finding\": \"Rapamycin extended median lifespan in mice by 9%-14% in mid-life studies by inhibiting mTORC1 and promoting autophagy\", \"source\": \"https://pmc.ncbi.nlm.nih.gov/articles/PMC12226543/\"}",
    "{\"timestamp\":\"2026-03-01T16:42:37Z\",\"topic\":\"longevity\",\"finding\":\"Rapamycin extended median lifespan in multiple mammalian studies at low doses by inhibiting mTORC1 with human trials ongoing as of 2025\",\"source\":\"fallback\"}",
    "{\"timestamp\":\"2026-03-02T01:45:00Z\",\"topic\":\"ai-agents\",\"finding\":\"Lovable AI agent scores 8\\/10 in SWE-bench autonomous multi-tenant CRM SaaS development\",\"source\":\"https:\\/\\/ai-agents-benchmark.com\\/\"}",
    "{\"timestamp\":\"2026-03-01T16:45:00Z\",\"topic\":\"ai-agents\",\"finding\":\"Lovable achieves 8/10 in 2026 AI coding agent benchmark for autonomous SaaS development\",\"source\":\"https://ai-agents-benchmark.com/\"}",
    "{\"timestamp\": \"2026-03-01T16:46:16.412516Z\", \"topic\": \"queue-research-tlt\", \"finding\": \"<|im_start|>\\n<|im_start|><|im_start|>\\n<|im_start|>\\n\\nFINDING: As of 2026-03-01, Fed funds futures imply 1.75 percentage point rate cuts in 2026, equivalent to seven 25bp cuts, with the first 25bp cut priced at >70% probability for the June 2026 FOMC meeting.  \\nIMPLICATION: This supports the TLT $90-101C Jan 2027 strikes if 10-year yields fall below 4.0 (breakeven for $90C) or 3.5 (breakeven for $101C), but risks a yield rebound if the March 2026 no-cut scenario materializes.  \\nCONFIDENCE: High \\u2014 CME FedWatch data and Schwab\\u2019s 2-3 cut forecast align with the 1.75pp cut assumption.  \\nNEXT_TASK: Monitor the March 2026 FOMC minutes for dovish language that could trigger a yield rebound before the June cut.\", \"source\": \"spark-queue/fin_20260301113932\", \"instrument\": \"TLT\", \"task_label\": \"FedWatch rate cut probability \\u2014 TLT position impact\", \"priority_was\": 6}",
    "{\"timestamp\":\"2026-03-01T16:47:00Z\",\"topic\":\"compound-synthesis\",\"finding\":\"Rapamycin prevents muscle loss in women while frontier AI agents demonstrate code accuracy at SWE-bench\",\"source\":\"synthesis\"}",
    "{\"timestamp\":\"2026-03-01T17:47:00Z\",\"topic\":\"compound-synthesis\",\"finding\":\"Low-dose Rapamycin interventions for longevity and incremental AI coding agent improvements both demonstrate gradual effectiveness through sustained application\",\"source\":\"synthesis\"}",
    "{\"timestamp\":\"2026-03-01T17:47:00Z\",\"topic\":\"compound-synthesis\",\"finding\":\"Low-dose rapamycin interventions and incremental AI coding improvements both demonstrate gradual effectiveness across biological and computational domains\",\"source\":\"synthesis\"}",
    "{\"timestamp\":\"2026-03-01T17:47:00Z\",\"topic\":\"compound-synthesis\",\"finding\":\"Gradual low-dose interventions show cross-domain effectiveness in both longevity research (Rapamycin) and AI system development (Lovable agent), with 14% lifespan extension matched by 8/10 SWE-bench accuracy improvements\",\"source\":\"synthesis\"}",
    "{\"timestamp\":\"2026-03-01T17:47:00Z\",\"topic\":\"compound-synthesis\",\"finding\":\"Low-dose Rapamycin extends mouse lifespan via autophagy while AI agents achieve 8/10 in autonomous SaaS coding benchmarks\",\"source\":\"synthesis\"}",
    "{\"timestamp\":\"2026-03-01T16:47:00Z\",\"topic\":\"compound-synthesis\",\"finding\":\"Low-dose rapamycin extends mouse lifespan through autophagy while ai agents improve autonomous coding benchmarks\",\"source\":\"synthesis\"}",
    "{\"timestamp\":\"2026-03-01T16:47:00Z\",\"topic\":\"compound-synthesis\",\"finding\":\"Low-dose Rapamycin improves longevity in mice by promoting autophagy while AI agents enhance SaaS development through incremental coding improvements\",\"source\":\"synthesis\"}"
  ],
  "kg_stats": "Entities: 361\nRelationships: 366\nAssociations: 135\nInsights: 0\nDomains: {\n  \"ai-agents\": 81,\n  \"longevity\": 78,\n  \"treasury-bonds\": 53,\n  \"tool-calling\": 47,\n  \"self-improvement\": 38,\n  \"cross-domain\": 17,\n  \"compound-synthesis\": 6,\n  \"local model inference\": 6,\n  \"self_improvement\": 6,\n  \"senolytics\": 4,\n  \"circadian biology\": 3,\n  \"10-year_Treasury_yield\": 2,\n  \"10-year_Treasury_yield_adjustment_intervals\": 2,\n  \"AI development\": 2,\n  \"Longevity\": 2,\n  \"ai-agents,longevity\": 2,\n  \"cross-domain-associations\": 2,\n  \"finance-cycles\": 2,\n  \"spaced_repetition_intervals\": 2,\n  \"tool-calling-improvements\": 2,\n  \"treasury\": 2,\n  \"treasury-bounds\": 2\n}",
  "last_synthesis": "daily-synthesis-2026-02-21.md",
  "synthesis_content": "# Daily Synthesis - 2026-02-21 (Cycle 2 - Evening Update)\n\nGenerated by: zeke-reason.sh (Claude Code autonomous reasoning layer)\nFeed entries analyzed: 193 total, 30 scored across 2 evaluation cycles\nKG state: 75 entities, 59 relationships, 9 associations, 8 domains\n\n---\n\n## System Status: DEGRADED\nALL 8 overnight queue jobs failed with gateway timeouts this morning (12:56-14:17 UTC).\nGateway PID 95262 is running, Spark reachable at 10.0.0.143:11434. All quality entries\ntoday came from the afternoon Reason cycle (Claude Opus), not the overnight Spark queue.\n\n---\n\n## 3 Key Strategic Insights\n\n### 1. TLT PRIORITY: Position Breakeven Analysis at 4.85% 20-Year Yield\n\nThe 20-year yield at 4.85% (DGS20, 2/19/2026) puts TLT approximately at $87-89.\nUsing TLT effective duration of ~17 years:\n\n| Position | Strike | Qty  | Approx Breakeven TLT | Required Yield Drop | Probability |\n|----------|--------|------|----------------------|---------------------|-------------|\n| $90C     | $90    | 650  | ~$93-95 at expiry    | ~55-85bps to 4.0%   | Moderate    |\n| $95C     | $95    | 300  | ~$98-100 at expiry   | ~85-105bps to 3.8%  | Low-Mod     |\n| $101C    | $101   | 3150 | ~$104-107 at expiry  | ~115bps to 3.7%     | Low         |\n| Shares   | -      | 1868 | At cost basis        | Any decline          | Moderate    |\n\nDuration math: 17yr \u00d7 0.85% yield drop = ~14.5% price increase \u2192 TLT $87 \u00d7 1.145 = ~$100.\nSo a move from 4.85% to 4.0% gets TLT to ~$100 \u2014 making $90C and $95C profitable, but\n$101C marginal. The $101C (3150 contracts) needs a recession-level catalyst.\n\nMacro signals this week:\n- Fed minutes: hawkish pause confirmed (bearish near-term for bonds)\n- Jan jobs: 130k (below 150k trend \u2014 mildly supportive)\n- 10-year: 4.1% (stable, not breaking lower)\n- RIKB auction data captured was ICELANDIC bonds (search error) \u2014 US data still needed\n- MOVE index level: NOT YET CAPTURED \u2014 critical gap\n\nTLT VERDICT: No immediate catalyst for the ~115bps rally $101C needs. The $90C position\nis more realistic. Watch: March FOMC (3/19), Q1 GDP, credit spread widening. Time decay\naccelerating \u2014 11 months to 1/15/27 expiry.\n\n### 2. Longevity Research Hit Peak Productivity \u2014 4 Score-5 Entries\n\nThe afternoon Reason cycle produced the best research day since tracking began:\n\na) p-tau217 commercial availability: 8 labs now offering testing (Labcorp test code\n   484390, Mayo PT217, Lucent, Genova, TrueHealthLabs, ALZpath, C2N, Quest). Cost\n   $195-$400. FDA cleared Lumipulse G pTau217/AB42 ratio May 2025. Insurance coverage\n   expanding. ACTIONABLE: Matt should consider testing given 3-4 year prediction window.\n\nb) AKL003 Phase 1b: Launched 2/19/2026 (2 days ago), actively recruiting ages 25-75.\n   Alpha Klotho mRNA in LNPs, IV administration, 2:1 randomization, single site at GARM\n   Clinic in Prospera, Roatan, Honduras. NOT on ClinicalTrials.gov (NCT07216781 unclear).\n\nc) DMTF1: Science Advances Jan 2026 (DOI: 10.1126/sciadv.ady5905). DMTF1 upregulation\n   rescues aged neural",
  "priorities_updated": "2026-03-01T10:00:52.261529+00:00",
  "priorities_content": "# Research Priorities \u2014 Updated 2026-03-01\n\n## Tier 1 \u2014 Actively Monitor\n1. **Rapamycin clinical trials** \u2014 PEARL trial Phase 2 ongoing; watch for full\n   results. Human safety/efficacy data is the gap to fill. Source: pmc.ncbi.nlm.nih.gov\n2. **AI agent reliability** \u2014 Tool-calling accuracy is the limiting factor for\n   Zeke autonomy. Monitor Berkeley BFCL leaderboard for model improvements.\n   Current ceiling: ~88% multi-step. Gap: real-world reliability below benchmark.\n\n## Tier 2 \u2014 Periodic Check (Weekly)\n3. **Spaced repetition implementation** \u2014 Apply double-spacing intervals to Zeke\n   feed review. Research is settled; priority shifts to implementation.\n4. **Treasury yields** \u2014 10Y at 3.95%, Fed holding. Monitor for rate cut signals\n   that affect TLT position.\n\n## Tier 3 \u2014 Diminishing Returns (Reduce Feed Weight)\n5. **tool-calling general** \u2014 Saturated. Consolidate to monthly summary.\n6. **compound-synthesis** \u2014 Derivable locally; not worth dedicated feed slots.\n7. **AI agent benchmarks (general)** \u2014 High noise/signal ratio; filter to\n   specific named tools only (Claude Code, Lovable, Cursor).\n\n## Feed Health Notes\n- Dedup pass needed: tool-calling topic has 8+ near-identical entries this cycle\n- compound-synthesis entries should be generated locally, not ingested as feed\n- Quality scoring working well; 4-5 scores are surfacing genuinely useful content\n",
  "gpu_stats": {
    "status": "OK",
    "gpu_util_pct": 0.0,
    "temp_c": 54.0,
    "power_w": 12.88,
    "gpu_name": "NVIDIA GB10"
  },
  "gateway_config": {
    "sessionTimeoutMs": "NOT SET",
    "timeoutMs": "NOT SET",
    "elevated": {},
    "byProvider": {
      "spark/qwen3:8b": {
        "allow": [
          "read",
          "memory_search",
          "session_status"
        ],
        "count": 3
      },
      "spark/qwen3-32b-32k": {
        "allow": [
          "exec",
          "read",
          "web_search",
          "memory_search",
          "web_fetch"
        ],
        "count": 5
      },
      "spark/deepseek-r1:32b": {
        "allow": [
          "exec",
          "read",
          "web_search",
          "memory_search",
          "web_fetch"
        ],
        "count": 5
      },
      "spark/deepseek-r1-32b-32k": {
        "allow": [
          "exec",
          "read"
        ],
        "count": 2
      }
    }
  },
  "gateway_process": {
    "pid": "90805",
    "memory_pct": "2.9",
    "uptime": "02-09:02:58",
    "status": "RUNNING"
  },
  "spark_status": {
    "status": "ONLINE",
    "loaded_models": [
      {
        "name": "nomic-embed-text:latest",
        "size_gb": 0.6
      },
      {
        "name": "qwen3:8b",
        "size_gb": 6.0
      },
      {
        "name": "qwen3-32b-32k:latest",
        "size_gb": 29.1
      }
    ]
  },
  "feed_quality": {
    "malformed_json": 0,
    "literal_timestamps": 0,
    "duplicates": 21,
    "no_new_dev": 0,
    "total": 506,
    "error_rate": 4.2
  },
  "crontab_status": {
    "total_entries": 7,
    "active": 7,
    "disabled_for_maint": 0,
    "has_queue": false,
    "has_overnight": false,
    "has_reason": false,
    "has_status_push": false
  },
  "last_jobs": [
    {
      "name": "treasury-bonds",
      "status": "success",
      "duration": 67,
      "grew": 1,
      "issues": [],
      "valid_entries": 1,
      "broken_entries": 0,
      "cycle_time": "9:51 AM",
      "cycle_num": 7
    },
    {
      "name": "longevity",
      "status": "success",
      "duration": 91,
      "grew": 3,
      "issues": [],
      "valid_entries": 3,
      "broken_entries": 0,
      "cycle_time": "9:51 AM",
      "cycle_num": 7
    },
    {
      "name": "ai-agents",
      "status": "success",
      "duration": 84,
      "grew": 2,
      "issues": [],
      "valid_entries": 2,
      "broken_entries": 0,
      "cycle_time": "9:51 AM",
      "cycle_num": 7
    },
    {
      "name": "self-improvement",
      "status": "success",
      "duration": 114,
      "grew": 1,
      "issues": [],
      "valid_entries": 1,
      "broken_entries": 0,
      "cycle_time": "9:51 AM",
      "cycle_num": 7
    },
    {
      "name": "compound-synthesis",
      "status": "success",
      "duration": 421,
      "grew": 11,
      "issues": [],
      "valid_entries": 4,
      "broken_entries": 7,
      "cycle_time": "9:51 AM",
      "cycle_num": 7
    },
    {
      "name": "treasury-bonds",
      "status": "success",
      "duration": 60,
      "grew": 1,
      "issues": [],
      "valid_entries": 1,
      "broken_entries": 0,
      "cycle_time": "10:30 AM",
      "cycle_num": 8
    },
    {
      "name": "longevity",
      "status": "success",
      "duration": 54,
      "grew": 2,
      "issues": [],
      "valid_entries": 1,
      "broken_entries": 1,
      "cycle_time": "10:30 AM",
      "cycle_num": 8
    },
    {
      "name": "ai-agents",
      "status": "success",
      "duration": 157,
      "grew": 5,
      "issues": [],
      "valid_entries": 5,
      "broken_entries": 0,
      "cycle_time": "10:30 AM",
      "cycle_num": 8
    },
    {
      "name": "self-improvement",
      "status": "fail",
      "duration": 52,
      "grew": 0,
      "issues": [],
      "valid_entries": null,
      "broken_entries": null,
      "cycle_time": "10:30 AM",
      "cycle_num": 8
    },
    {
      "name": "compound-synthesis",
      "status": "success",
      "duration": 124,
      "grew": 3,
      "issues": [],
      "valid_entries": 3,
      "broken_entries": 0,
      "cycle_time": "10:30 AM",
      "cycle_num": 8
    },
    {
      "name": "treasury-bonds",
      "status": "fail",
      "duration": 50,
      "grew": 0,
      "issues": [],
      "valid_entries": null,
      "broken_entries": null,
      "cycle_time": "11:10 AM",
      "cycle_num": 9
    },
    {
      "name": "longevity",
      "status": "success",
      "duration": 67,
      "grew": 2,
      "issues": [],
      "valid_entries": 2,
      "broken_entries": 0,
      "cycle_time": "11:10 AM",
      "cycle_num": 9
    },
    {
      "name": "ai-agents",
      "status": "success",
      "duration": 202,
      "grew": 4,
      "issues": [],
      "valid_entries": 4,
      "broken_entries": 0,
      "cycle_time": "11:10 AM",
      "cycle_num": 9
    },
    {
      "name": "self-improvement",
      "status": "fail",
      "duration": 41,
      "grew": 0,
      "issues": [],
      "valid_entries": null,
      "broken_entries": null,
      "cycle_time": "11:10 AM",
      "cycle_num": 9
    },
    {
      "name": "compound-synthesis",
      "status": "success",
      "duration": 168,
      "grew": 4,
      "issues": [],
      "valid_entries": 4,
      "broken_entries": 0,
      "cycle_time": "11:10 AM",
      "cycle_num": 9
    },
    {
      "name": "treasury-bonds",
      "status": "success",
      "duration": 70,
      "grew": 1,
      "issues": [],
      "valid_entries": 1,
      "broken_entries": 0,
      "cycle_time": "11:51 AM",
      "cycle_num": 10
    },
    {
      "name": "longevity",
      "status": "success",
      "duration": 86,
      "grew": 2,
      "issues": [],
      "valid_entries": 2,
      "broken_entries": 0,
      "cycle_time": "11:51 AM",
      "cycle_num": 10
    },
    {
      "name": "ai-agents",
      "status": "success",
      "duration": 100,
      "grew": 2,
      "issues": [],
      "valid_entries": 2,
      "broken_entries": 0,
      "cycle_time": "11:51 AM",
      "cycle_num": 10
    },
    {
      "name": "self-improvement",
      "status": "success",
      "duration": 42,
      "grew": 1,
      "issues": [],
      "valid_entries": 1,
      "broken_entries": 0,
      "cycle_time": "11:51 AM",
      "cycle_num": 10
    },
    {
      "name": "compound-synthesis",
      "status": "success",
      "duration": 277,
      "grew": 8,
      "issues": [],
      "valid_entries": 7,
      "broken_entries": 1,
      "cycle_time": "11:51 AM",
      "cycle_num": 10
    }
  ],
  "recent_cycles": [
    {
      "cycle": 7,
      "window": "daytime",
      "timestamp": "2026-03-01T09:51:06.890356",
      "time_display": "9:51 AM",
      "feed_growth": 11,
      "jobs": [
        {
          "name": "treasury-bonds",
          "status": "success",
          "duration": 67,
          "grew": 1,
          "issues": [],
          "valid_entries": 1,
          "broken_entries": 0,
          "cycle_time": "9:51 AM",
          "cycle_num": 7
        },
        {
          "name": "longevity",
          "status": "success",
          "duration": 91,
          "grew": 3,
          "issues": [],
          "valid_entries": 3,
          "broken_entries": 0,
          "cycle_time": "9:51 AM",
          "cycle_num": 7
        },
        {
          "name": "ai-agents",
          "status": "success",
          "duration": 84,
          "grew": 2,
          "issues": [],
          "valid_entries": 2,
          "broken_entries": 0,
          "cycle_time": "9:51 AM",
          "cycle_num": 7
        },
        {
          "name": "self-improvement",
          "status": "success",
          "duration": 114,
          "grew": 1,
          "issues": [],
          "valid_entries": 1,
          "broken_entries": 0,
          "cycle_time": "9:51 AM",
          "cycle_num": 7
        },
        {
          "name": "compound-synthesis",
          "status": "success",
          "duration": 421,
          "grew": 11,
          "issues": [],
          "valid_entries": 4,
          "broken_entries": 7,
          "cycle_time": "9:51 AM",
          "cycle_num": 7
        }
      ]
    },
    {
      "cycle": 8,
      "window": "daytime",
      "timestamp": "2026-03-01T10:30:02.193624",
      "time_display": "10:30 AM",
      "feed_growth": 10,
      "jobs": [
        {
          "name": "treasury-bonds",
          "status": "success",
          "duration": 60,
          "grew": 1,
          "issues": [],
          "valid_entries": 1,
          "broken_entries": 0,
          "cycle_time": "10:30 AM",
          "cycle_num": 8
        },
        {
          "name": "longevity",
          "status": "success",
          "duration": 54,
          "grew": 2,
          "issues": [],
          "valid_entries": 1,
          "broken_entries": 1,
          "cycle_time": "10:30 AM",
          "cycle_num": 8
        },
        {
          "name": "ai-agents",
          "status": "success",
          "duration": 157,
          "grew": 5,
          "issues": [],
          "valid_entries": 5,
          "broken_entries": 0,
          "cycle_time": "10:30 AM",
          "cycle_num": 8
        },
        {
          "name": "self-improvement",
          "status": "fail",
          "duration": 52,
          "grew": 0,
          "issues": [],
          "valid_entries": null,
          "broken_entries": null,
          "cycle_time": "10:30 AM",
          "cycle_num": 8
        },
        {
          "name": "compound-synthesis",
          "status": "success",
          "duration": 124,
          "grew": 3,
          "issues": [],
          "valid_entries": 3,
          "broken_entries": 0,
          "cycle_time": "10:30 AM",
          "cycle_num": 8
        }
      ]
    },
    {
      "cycle": 9,
      "window": "daytime",
      "timestamp": "2026-03-01T11:10:25.955024",
      "time_display": "11:10 AM",
      "feed_growth": 10,
      "jobs": [
        {
          "name": "treasury-bonds",
          "status": "fail",
          "duration": 50,
          "grew": 0,
          "issues": [],
          "valid_entries": null,
          "broken_entries": null,
          "cycle_time": "11:10 AM",
          "cycle_num": 9
        },
        {
          "name": "longevity",
          "status": "success",
          "duration": 67,
          "grew": 2,
          "issues": [],
          "valid_entries": 2,
          "broken_entries": 0,
          "cycle_time": "11:10 AM",
          "cycle_num": 9
        },
        {
          "name": "ai-agents",
          "status": "success",
          "duration": 202,
          "grew": 4,
          "issues": [],
          "valid_entries": 4,
          "broken_entries": 0,
          "cycle_time": "11:10 AM",
          "cycle_num": 9
        },
        {
          "name": "self-improvement",
          "status": "fail",
          "duration": 41,
          "grew": 0,
          "issues": [],
          "valid_entries": null,
          "broken_entries": null,
          "cycle_time": "11:10 AM",
          "cycle_num": 9
        },
        {
          "name": "compound-synthesis",
          "status": "success",
          "duration": 168,
          "grew": 4,
          "issues": [],
          "valid_entries": 4,
          "broken_entries": 0,
          "cycle_time": "11:10 AM",
          "cycle_num": 9
        }
      ]
    },
    {
      "cycle": 10,
      "window": "daytime",
      "timestamp": "2026-03-01T11:51:59.789069",
      "time_display": "11:51 AM",
      "feed_growth": 13,
      "jobs": [
        {
          "name": "treasury-bonds",
          "status": "success",
          "duration": 70,
          "grew": 1,
          "issues": [],
          "valid_entries": 1,
          "broken_entries": 0,
          "cycle_time": "11:51 AM",
          "cycle_num": 10
        },
        {
          "name": "longevity",
          "status": "success",
          "duration": 86,
          "grew": 2,
          "issues": [],
          "valid_entries": 2,
          "broken_entries": 0,
          "cycle_time": "11:51 AM",
          "cycle_num": 10
        },
        {
          "name": "ai-agents",
          "status": "success",
          "duration": 100,
          "grew": 2,
          "issues": [],
          "valid_entries": 2,
          "broken_entries": 0,
          "cycle_time": "11:51 AM",
          "cycle_num": 10
        },
        {
          "name": "self-improvement",
          "status": "success",
          "duration": 42,
          "grew": 1,
          "issues": [],
          "valid_entries": 1,
          "broken_entries": 0,
          "cycle_time": "11:51 AM",
          "cycle_num": 10
        },
        {
          "name": "compound-synthesis",
          "status": "success",
          "duration": 277,
          "grew": 8,
          "issues": [],
          "valid_entries": 7,
          "broken_entries": 1,
          "cycle_time": "11:51 AM",
          "cycle_num": 10
        }
      ]
    }
  ],
  "evaluation_count": 30,
  "recent_evaluations": [
    "{\"timestamp\": \"2026-02-21T14:30:00Z\", \"eval_date\": \"2026-02-21\", \"eval_cycle\": 2, \"feed_line\": 184, \"feed_ts\": \"2026-02-21T15:30:00Z\", \"topic\": \"longevity research\", \"subtopic\": \"p-tau217 commercial availability\", \"novelty_score\": 5, \"reasoning\": \"Extremely detailed: 8 named labs (Labcorp test code 484390, Mayo PT217, Lucent, Genova, TrueHealthLabs, ALZpath, C2N, Quest), exact pricing ($195-$400), FDA clearance status, insurance implications. Directly actionable for Matt.\"}",
    "{\"timestamp\": \"2026-02-21T14:30:00Z\", \"eval_date\": \"2026-02-21\", \"eval_cycle\": 2, \"feed_line\": 185, \"feed_ts\": \"2026-02-21T15:31:00Z\", \"topic\": \"longevity research\", \"subtopic\": \"AKL003 Phase 1b trial\", \"novelty_score\": 5, \"reasoning\": \"Named trial launched 2 days ago, specific design (randomized double-blind 2:1), population (25-75), dosing schedule (IV q4wks x2), single site Honduras. Answered our P1 question on enrollment status.\"}",
    "{\"timestamp\": \"2026-02-21T14:30:00Z\", \"eval_date\": \"2026-02-21\", \"eval_cycle\": 2, \"feed_line\": 186, \"feed_ts\": \"2026-02-21T15:32:00Z\", \"topic\": \"longevity research\", \"subtopic\": \"DMTF1 neural stem cell\", \"novelty_score\": 5, \"reasoning\": \"DOI 10.1126/sciadv.ady5905, PubMed 41481722, specific mechanism (DMTF1 > Arid2/Ss18 > SWI/SNF > H3K27ac > E2F), named institution NUS. Excellent primary source depth.\"}",
    "{\"timestamp\": \"2026-02-21T14:30:00Z\", \"eval_date\": \"2026-02-21\", \"eval_cycle\": 2, \"feed_line\": 187, \"feed_ts\": \"2026-02-21T15:33:00Z\", \"topic\": \"longevity research\", \"subtopic\": \"metformin exercise blunting\", \"novelty_score\": 5, \"reasoning\": \"3 named RCTs (MASTERS 2019, Rutgers 2025, MET-PREVENT 2025 Lancet), specific figures (p=.003, 50% fitness blunting, 1700mg/d dose), mechanistic detail (mitochondrial complex I). Critical protocol guidance.\"}",
    "{\"timestamp\": \"2026-02-21T14:30:00Z\", \"eval_date\": \"2026-02-21\", \"eval_cycle\": 2, \"feed_line\": 188, \"feed_ts\": \"2026-02-21T15:34:00Z\", \"topic\": \"AI agent architectures\", \"subtopic\": \"ring attention million-token\", \"novelty_score\": 3, \"reasoning\": \"Good technical detail (Meta 77s prefill, O(n) complexity, Pass-KV) but context window sizes well-known. Production timeline speculative. Moderate relevance to Zeke architecture.\"}",
    "{\"timestamp\": \"2026-02-21T14:30:00Z\", \"eval_date\": \"2026-02-21\", \"eval_cycle\": 2, \"feed_line\": 189, \"feed_ts\": \"2026-02-21T12:56:06Z\", \"topic\": \"longevity\", \"subtopic\": \"PEARL follow-up\", \"novelty_score\": 1, \"reasoning\": \"Malformed JSON (unquoted timestamp, stringified arrays). Content is null: explicitly states no new data. Confirms known gap.\"}",
    "{\"timestamp\": \"2026-02-21T14:30:00Z\", \"eval_date\": \"2026-02-21\", \"eval_cycle\": 2, \"feed_line\": 190, \"feed_ts\": \"2026-02-21T12:57:00Z\", \"topic\": \"treasury-bonds\", \"subtopic\": \"RIKB auction data\", \"novelty_score\": 2, \"reasoning\": \"RIKB = Icelandic government bonds, NOT US Treasury 20-year. Wrong search result for our TLT focus. Bid-to-cover data is specific but irrelevant to portfolio.\"}",
    "{\"timestamp\": \"2026-02-21T14:30:00Z\", \"eval_date\": \"2026-02-21\", \"eval_cycle\": 2, \"feed_line\": 191, \"feed_ts\": \"LITERAL_VAR\", \"topic\": \"ai-agents\", \"subtopic\": \"Microsoft Agent Framework duplicate\", \"novelty_score\": 1, \"reasoning\": \"Duplicate of line 183 with less detail. Literal shell variable as timestamp. No new information.\"}",
    "{\"timestamp\": \"2026-02-21T14:30:00Z\", \"eval_date\": \"2026-02-21\", \"eval_cycle\": 2, \"feed_line\": 192, \"feed_ts\": \"LITERAL_VAR\", \"topic\": \"self-improvement\", \"subtopic\": \"novelty-seeking habits\", \"novelty_score\": 2, \"reasoning\": \"Vague insights with fabricated confidence scores (0.85, 0.78) but no source citations. Literal shell variable timestamp. Likely model confabulation.\"}",
    "{\"timestamp\": \"2026-02-21T14:30:00Z\", \"eval_date\": \"2026-02-21\", \"eval_cycle\": 2, \"feed_line\": 193, \"feed_ts\": \"LITERAL_VAR\", \"topic\": \"tool-calling\", \"subtopic\": \"no developments\", \"novelty_score\": 1, \"reasoning\": \"Explicitly no new developments. Correct to skip per priorities (DEPRIORITIZED). Literal shell variable timestamp.\"}"
  ],
  "self_heal_log": "# Self-Heal Log\n\n## 2026-02-26 \u2014 Dashboard Fix (Manual)\n- Cleaned stale byProvider entries (removed unused models)\n- Updated ops-status.md (was showing DEGRADED from Feb 21)\n- Deployed MCP watchdog (5-min cron, auto-restart + Telegram)\n- quality-eval job: diagnosed as failing, needs scheduler prompt fix\n\n## 2026-02-26 \u2014 MCP Watchdog Deployed\n- ~/zeke-mcp-watchdog.py checks process, port, SSE every 5 min\n- Auto-restarts via launchctl, Telegram alerts on failure\n- Added to crontab alongside existing system watchdog\n\n## 2026-02-22 \u2014 L2 Autonomy Deployed  \n- Watchdog every 10min auto-repairs scheduler via launchctl\n- Telegram alerts on failures\n- Verified: scheduler kill \u2192 repaired in 35s\n",
  "ops_status": "# Operational Status \u2014 2026-02-26\n\n## System Health: HEALTHY\n\n### Pipeline Summary (automated via Python scheduler)\n- Scheduler: Running, daytime+overnight windows\n- Feed: 1,029 entries, growing ~30-40/overnight cycle\n- Success rate: 89% (89/100 jobs today)\n- Cost: $0/day (all local Spark models)\n- Timeouts: 0 today\n\n### Active Research Jobs (Python scheduler)\n- treasury-bonds: \u2705 running\n- longevity: \u2705 running  \n- ai-agents: \u2705 running\n- self-improvement: \u2705 running\n- tool-calling: \u26a0\ufe0f intermittent failures\n- compound-synthesis: \u2705 running\n- quality-eval: \u274c failing (needs investigation)\n\n### Active OpenClaw Cron Jobs\n- tlt-alert-scanner: \u2705 enabled (market hours)\n- association-engine: \u2705 enabled (every 4h)\n- system-health-alert: \u2705 enabled (every 2h)\n- kg-extractor: \u2705 enabled (every 2h)\n- system-doctor: \u2705 enabled (every 2h)\n\n### Infrastructure\n| Component       | Status  | Notes                              |\n|-----------------|---------|-------------------------------------|\n| Gateway         | RUNNING | 23+ hours uptime                    |\n| Spark server    | ONLINE  | qwen3-32b-32k, nomic-embed, qwen3:8b |\n| MCP Server      | RUNNING | Port 8100, Tailscale funnel active  |\n| Dashboard       | LIVE    | GitHub Pages + local:3333           |\n| Watchdogs       | ACTIVE  | System (10min) + MCP (5min)         |\n\n### Automation Layers\n- L1 (Execution): \u2705 DEPLOYED \u2014 scheduler, guardian, quality gate\n- L2 (Oversight): \ud83d\udd28 IN PROGRESS (~60%) \u2014 dashboard live, watchdogs active, quality-eval broken\n- L3 (Intelligence): \ud83d\udccb PLANNED \u2014 cross-domain synthesis, prompt evolution\n",
  "zeke-queue_tail": [],
  "zeke-reason-error_tail": [],
  "cron_job_count": 7,
  "strategic_context": "# Claude Strategic Context \u2014 Zeke Ecosystem\n\nLast updated: 2026-03-01T04:00:00Z\nPurpose: Claude's extended memory.\n\n> **MORNING SESSION**: Read `morning-execution-plan.md` first. Build sequence is defined. Don't improvise. Captures decisions, mistakes, principles, and Matt's patterns so every conversation starts informed. READ THIS FIRST before any session. Update it before ending any session that makes structural changes.\n\n---\n\n## Matt's Core Values\n- Never ask questions with obvious answers \u2014 make the safe/obvious choice automatically\n- Anticipate 2 steps ahead. If something will be needed, build it now\n- Operational requirements BEFORE features (permissions, monitoring, error handling, self-healing)\n- Longitudinal data over snapshots \u2014 show progression over time\n- Be concise. Don't describe what you built \u2014 let output speak\n- Matt is a strategist, not an engineer. Minimize cognitive load\n- Never touch running processes. If pipeline is active, only modify dashboard/monitoring\n- When presenting options, choose the safe default. Only ask if genuinely ambiguous\n- **Assessment before action**: state what you confirmed about a file/component before modifying or deprecating it. Out loud, visible, not just internal\n- **Memory writes are non-optional**: every structural session ends with session-journal + anti-patterns + this file updated\n\n---\n\n## Current Architecture (as of 2026-02-28)\n\n### Camel Finance Intelligence Pipeline (CANONICAL)\n```\nFETCH  (9:00am daily, jobs.json camel-morning-fetch)\n  \u2192 camel-fetch-transcripts.py\n  \u2192 writes {vid_id}.json pipeline_version=\"v3-fetch-only\"\n  \u2192 ~/.openclaw/workspace/memory/camel-transcripts/\n\nANALYZE (9:30am daily jobs.json + every 6h crontab)\n  \u2192 camel-yt-pipeline-v2.py  \u2190 SINGLE CANONICAL PIPELINE\n      \u2192 acquire_spark(\"camel-pipeline-v2\", timeout=300)\n      \u2192 fetch_full_transcript() from YouTube\n      \u2192 camel_chunked_analyzer.analyze_transcript()\n          \u2192 zeke_rag_query.py (subprocess python3.9 \u2192 ChromaDB RAG context)\n          \u2192 zeke_dispatch (Haiku T2 forced, $0.003/chunk, Spark fallback)\n      \u2192 camel_thesis_ledger.ingest_analysis() (conviction, drift, conflicts)\n      \u2192 append_to_feed() \u2192 learning-feed.jsonl\n      \u2192 save_transcript() \u2192 writes pipeline_version=\"v2\"\n      \u2192 update camel-yt-state.json processed_ids\n      \u2192 release_spark(), sleep(30)\n\nRAG REFRESH (3:00am daily, jobs.json rag-nightly-reembed)\n  \u2192 rag-nightly-reembed.py\n  \u2192 re-embeds source transcripts to ChromaDB zeke_knowledge (913 vectors)\n  \u2192 uses nomic-embed-text via Ollama\n  \u2192 DOES NOT embed Haiku output \u2014 feedback loop gap (Phase 3)\n```\n\n**Deprecated (off-schedule, file preserved):**\n- `camel-rag-analyzer.py` \u2014 had no Spark lock, no thesis ledger, duplicate RAG impl\n\n### Scheduler Layer\n**crontab (system-level):**\n- `zeke-scheduler.py --guardian` every minute (master heartbeat)\n- `camel-yt-pipeline-v2.py` every 6h\n- `zeke-dedup.py` 3am, session cleanup 4am, `zeke-nightly-synthesis.sh` 5am\n- `fetch_prices.py` 6am, `trade_alerts.py` ev"
}